Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players

Jan 11 2023

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

SIFI’s Parasitic Eye Infection Drug & Biosimilar Aflibercept Among Raft Of EU Filings

Jun 17 2022

Finance Watch: Certain Offerings Find Their Way To Investors In Tough Market

Jun 22 2022

Celltrion Allies With Rani As Exclusive Oral Ustekinumab Partner

Jan 09 2023

Coherus Makes U-Turn On Eylea Biosimilar With Klinge BioPharma Deal

Jan 09 2023

Hikma Adds Another Celltrion Biosimilar To MENA Collaboration

Jan 06 2023

Amneal Reveals Orion As European Partner

Jan 05 2023

Hikma Delivers On Authorized Xyrem In US

Jan 03 2023

Zentiva Grows In Italy With Acquisition Of Sanofi OTC Brands

Jan 03 2023

Finance Watch: Insilico Raises $255m To Take AI-Discovered Drugs Into The Clinic

Jun 23 2021

Synaffix Aims For Top ADC Tech Provider Spot After Inking MacroGenics Deal

Feb 08 2022

Deal Watch: Genentech Sees Bicycle As Route To Novel Targeted Cancer Immunotherapies

Feb 25 2020

IRA Already Impacting Merck & Co. BD Decisions, CEO Davis Says

Jan 05 2023

Amgen And Synaffix Alliance Could Be Biggest Preclinical ADC Licensing Deal Yet

Jan 05 2023

Merck KGaA Cancer Deal-Making Spree Continues With PDS Tie-Up

Jan 04 2023

Stalicla Seals Deal To Advance Novartis Drug For Cocaine Misuse

Jan 09 2023

Fate Uncertain As Cell Therapy Biotech Pulls Out Of J&J Deal, Restructures

Jan 06 2023

Finance Watch: VC Round Extensions Attractive While Stock Market Wobbles

Jan 06 2023

BioNTech Beefs Up AI/ML Investment With InstaDeep Buy

Jan 10 2023

Ipsen Eyes Opportunity In Rare Liver Diseases With Albireo Buy

Jan 09 2023

Chiesi Expands Its Rare Disease Reach With $1.48bn Amryt Buyout

Jan 09 2023

AstraZeneca Nabs CinCor’s Hypertension Asset In $1.3bn Acquisition

Jan 10 2023

M&A Has Been Down, But EY Argues Conditions Are Right For An Uptick In 2023

Jan 09 2023

EVOQ Partners With Gilead On NanoDisc Approach To RA, Lupus

Jan 03 2023

Regeneron And Bluebird Team Up In Cell Therapy "Joint Venture"-Style Deal

Aug 06 2018

Deal Watch: Gemini Goes Through Second Re-Invention Via Reverse Merger With Disc Medicine

Aug 10 2022

Equillium Buys Metacrine For Its Cash, Will Outsource Lead Drug Candidate

Sep 07 2022

Merck & Co Closing In On Seagen Acquisition

Jul 08 2022

Sandoz Ups Biosimilar Game With Alteogen Subcutaneous Tech Deal

Jan 04 2023

Related Companies

UCB S.A.

Myrtelle Inc.

SIFI S.p.A.

Prokarium Ltd.

GreenLight Biosciences Holdings

EpiVax, Inc.

Aqemia

Asklepios BioPharmaceutical, Inc.

ReCode Therapeutics

EVQLV, Inc.

Genetix Biotherapeutics

2seventy Bio, Inc.

Regeneron Pharmaceuticals, Inc.

Acelyrin, Inc.

ValenzaBio, Inc.

Ensoma

Twelve Bio ApS

Fujifilm Cellular Dynamics Inc.

Caris Life Sciences

Xencor, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window